60 degrees pharmaceuticals announces first quarter 2025 results

Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. gross profit increased 124% to $90.3 thousand.
SXTP Ratings Summary
SXTP Quant Ranking